I broke my right humerus, so posts will be limited for a few weeks

The paper below reanalyzes data from an Israeli study on Covid case rates following Pfizer-BioNTech vaccination. https://www.medrxiv.org/content/10.1101/2021.02.01.21250957v1 What is important to note is that the data were obtained from an Israeli HMO in which 352,000 people were vaccinated, and 3,098 got Covid afterwards.  These are very big numbers and should be reliable.  I have seen…

The courageous BMJ and editor Fiona Godlee have dared to suggest the only way forward through the quicksand of clinical trial data in which we find ourselves.  When only the manufacturer knows what is in a drug’s database, and the manufacturer’s primary duty is to shareholders, medicine progresses backwards to a new Dark Age. Simply,…

I am posting the entire Reuters story below. Is it funny, pathetic, or both? CDC Director Tom Frieden promised Congress to appoint a senior official to oversee lab security in a 2012 letter responding to a Congressional inquiry. Asked about this person at the House Energy and Commerce Oversight and Investigations Hearing on Wednesday (at…

Estimated 73% of US now immune to omicron: Is that enough? It’s an estimate.  We have no idea whether it equates to reality.  But it does indicate that the narrative has changed. These numbers come from Bill Gates’ tricky Institute for Health Metrics and Evaluation at the University of Washington.  If memory serves, he supported the…

Just out as a provisional pdf (final version is in production), 3 scientists have reviewed the totality of the published data on Ebola therapeutics, and come up with a framework for combining the use of drugs for their potential synergistic effects.  For me, this put many disparate facts about Ebola into focus, providing much of…

Poland served as “faculty” for this little paper, whose goal was to push flu vaccinations beyond the end of flu season, helping to use up the oversupply: Access to influenza vaccination is no longer constrained by problems in supply and distribution, as more manufacturers are providing more influenza vaccine to the US market than ever before….